Inhibition of PRMT5 by the small-molecule compounds GSK3203591 or GSK3326595 has been reported to act antiproliferatively on mantle cell lymphoma, both in vivo and in vitro (Chan-Penebre et al., 2015; Gerhart et al., 2018). This evidence concerns the gene PRMT5 and mantle cell lymphoma.